Rein Therapeutics, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Rein Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $1.00K, a 99.01% decline year-over-year.
- Rein Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-09-30 was $42.00K.
- Rein Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $101.00K.
- Rein Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-09-30 was $27.00K.
- Rein Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $4.00K, a 97.20% decline from fiscal 2024.
- Rein Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $143.00K.
- Rein Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $75.00K.
- Rein Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2019 was $165.00K, a 292.86% increase from fiscal 2018.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2025-12-31 | $4.00K 10-K · filed 2026-03-26 | |
| 2025-06-30 | $1.00K 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $143.00K 10-K · filed 2026-03-26 | |
| 2024-09-30 | $42.00K 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $101.00K 10-Q · filed 2025-11-14 | |
| 2021-12-31 | $75.00K 10-K · filed 2023-03-20 | |
| 2021-09-30 | $27.00K 10-Q · filed 2022-11-01 | |
| 2021-06-30 | $47.00K 10-Q · filed 2022-11-01 | |
| 2019-12-31 | $165.00K 10-K · filed 2021-03-24 | |
| 2019-03-31 | $165.00K 10-Q · filed 2020-11-12 | |
| 2018-12-31 | $42.00K 10-K · filed 2020-03-30 | |
| 2018-06-30 | $12.00K 10-Q · filed 2019-11-07 | $59.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-03-31 | $16.00K 10-Q · filed 2019-11-07 | |
| 2017-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $111.00K 10-K · filed 2019-03-29 |
| 2017-09-30 | $20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | |
| 2016-12-31 | $23.00K 10-K · filed 2018-04-02 | |
| 2015-12-31 | $52.00K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |